Redeye is happy to see that Railcare and LKAB have signed a 5-year agreement with a total value of ~...
DT reports Q3 results on Oct 29. The growth rate of MBU still lags those of SBU and IBU, but its sta...
Weak shipping volumes and declining crude oil prices could keep organic revenue growth relatively mo...
Sales growth of +7.8% and 20% EBIT margin in Q3e EBITDA '24e-'26e revised down 1.
Redeye takes a positive stance towards the partial divestment of Aspire.
Redeye expects a stable Q2 report from Lagercrantz with muted organic growth yet solid margins.
Förvärvet av TrustPlay, med tillhörande teknikportfölj, positionerar Tangiamo i framkant av den växa...
Redeye lowers its forecasts for Q3 and 2024 somewhat on the back of a slightly softer outlook in Nor...
Redeye offers a preview of Doro's Q3 results set to be released on October 25.
We cut '24e-'26e EBITA by 21-4%... ...due to weaker IT consulting market data '25e EV/EBITA of ~7x ...
Minor near-term estimate cuts following the cyberattack Outlook for order intake unchanged NTM EV/EB...
We trim '24e-'26e ARR by 1% on continued macro weakness Still awaiting a return in B2C business mome...
Solid Q3e with 7% organic growth and 22% EBITDA growth US market could be sluggish again, but focus ...
STENOCARE announced on October 14th that the company has updated the sales guidance for 2024, from g...
Redeye expects a stable Q3 report from Addnode with limited growth yet solid margins.
Redeye has a positive view on the news from this morning, announcing that Saniona's collaboration wi...
Redeye comments on Truecaller ahead of its Q3 results, which are due on 7 November.
Lumi Gruppen announced a trading update today for the school year 2024-25.
VIMAB Group är en industrikoncern verksamt inom miljö, elektrifiering och near-shoring.
Redeye shares its preview of BONESUPPORT’s Q3 2024 results, due October 24.